Lindbrook Capital »

SPDR S&P Pharmaceuticals shares owned by Lindbrook Capital

Quarter-by-quarter ownership of SPDR S&P Pharmaceuticals (XPH) shares owned by Lindbrook Capital from 13F filings

Historical chart of Lindbrook Capital investment in SPDR S&P Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Pharmaceuticals held by Lindbrook Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Pharmaceuticals by Lindbrook Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $17k 395 43.13
2023-12-31 $16k 395 41.62

More positions owned by Lindbrook Capital

Vanguard Total Stk Mkt Etf (VTI)
Vanguard Total Intl Stock Idex Etf Etf (VXUS)
Golub Cap Bdc Cef (GBDC)
Apple Stock (AAPL)
Spdr S&p 500 Etf Trust Etf (SPY)
Ishares Russell 1000 Growth Etf Etf (IWF)
Nvidia Corporation Stock (NVDA)
Microsoft Stock (MSFT)
Rpar Risk Parity Etf Etf (RPAR)
Ishares Russell 1000 Value Etf Etf (IWD)
Amazon.com Stock (AMZN)
Powershares Qqq Tr Etf (QQQ)
Oaktree Specialty Lending Corp Cef (OCSL)
Vertex Pharmaceuticals In Stock (VRTX)
Broadcom Stock (AVGO)

View all positions for Lindbrook Capital

Top funds holding SPDR S&P Pharmaceuticals

Bank of America Corporation
Wells Fargo & Company
Goldman Sachs Group
Healthcare Of Ontario Pension Plan Trust Fund
First Citizens Bank & Trust
Bnp Paribas Arbitrage, Snc
Envestnet Portfolio Solutions
Wharton Business Group
UBS Group
MAI Wealth Advisors
Kingsview Wealth Management
Pnc Financial Services
Royal Bank of Canada
Citadel Advisors
AE Wealth Management

View all funds holding SPDR S&P Pharmaceuticals